Search Results
BUL 457, Pediatric Endocrine Unit, Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, USA
Search for other papers by Madhusmita Misra in
Google Scholar
PubMed
Search for other papers by Anne Klibanski in
Google Scholar
PubMed
is expected to increase to as much as 4% ( Smink et al . 2013 ). Subtypes of AN include the restrictive and the binge–purge subtypes, both of which are associated with low body weight. Most available data on effects of AN on bone metabolism are based
Department of Endocrinology and Diabetes, Murdoch Childrens Research Institute, Department of Paediatrics, Prostate and Breast Cancer Research Group, Department of Medicine and Bone and Mineral Service, Royal Children's Hospital, Parkville, Melbourne, Victoria 3052, Australia
Search for other papers by Anurag Bajpai in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Murdoch Childrens Research Institute, Department of Paediatrics, Prostate and Breast Cancer Research Group, Department of Medicine and Bone and Mineral Service, Royal Children's Hospital, Parkville, Melbourne, Victoria 3052, Australia
Department of Endocrinology and Diabetes, Murdoch Childrens Research Institute, Department of Paediatrics, Prostate and Breast Cancer Research Group, Department of Medicine and Bone and Mineral Service, Royal Children's Hospital, Parkville, Melbourne, Victoria 3052, Australia
Search for other papers by Peter J Simm in
Google Scholar
PubMed
Search for other papers by Stephen J McPherson in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Murdoch Childrens Research Institute, Department of Paediatrics, Prostate and Breast Cancer Research Group, Department of Medicine and Bone and Mineral Service, Royal Children's Hospital, Parkville, Melbourne, Victoria 3052, Australia
Department of Endocrinology and Diabetes, Murdoch Childrens Research Institute, Department of Paediatrics, Prostate and Breast Cancer Research Group, Department of Medicine and Bone and Mineral Service, Royal Children's Hospital, Parkville, Melbourne, Victoria 3052, Australia
Search for other papers by Vincenzo C Russo in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Murdoch Childrens Research Institute, Department of Paediatrics, Prostate and Breast Cancer Research Group, Department of Medicine and Bone and Mineral Service, Royal Children's Hospital, Parkville, Melbourne, Victoria 3052, Australia
Department of Endocrinology and Diabetes, Murdoch Childrens Research Institute, Department of Paediatrics, Prostate and Breast Cancer Research Group, Department of Medicine and Bone and Mineral Service, Royal Children's Hospital, Parkville, Melbourne, Victoria 3052, Australia
Search for other papers by Walid J Azar in
Google Scholar
PubMed
Search for other papers by John D Wark in
Google Scholar
PubMed
Search for other papers by Gail P Risbridger in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Murdoch Childrens Research Institute, Department of Paediatrics, Prostate and Breast Cancer Research Group, Department of Medicine and Bone and Mineral Service, Royal Children's Hospital, Parkville, Melbourne, Victoria 3052, Australia
Department of Endocrinology and Diabetes, Murdoch Childrens Research Institute, Department of Paediatrics, Prostate and Breast Cancer Research Group, Department of Medicine and Bone and Mineral Service, Royal Children's Hospital, Parkville, Melbourne, Victoria 3052, Australia
Search for other papers by George A Werther in
Google Scholar
PubMed
studies were not performed in peripubertal males. Short-term follow-up (2–3 years) of boys treated with aromatase inhibitors has not shown significant adverse effects on areal bone density ( Wickman et al . 2003 ), body composition ( Hero et al . 2006 a
Search for other papers by R Hardy in
Google Scholar
PubMed
Search for other papers by M S Cooper in
Google Scholar
PubMed
Introduction Chronic inflammatory diseases are frequently associated with systemic bone loss. The mechanisms underlying this bone loss are complex and interrelated. These mechanisms appear, however, to be ultimately mediated through effects on the
Search for other papers by Fiona Roberts in
Google Scholar
PubMed
Search for other papers by Greg Markby in
Google Scholar
PubMed
Search for other papers by Scott Dillon in
Google Scholar
PubMed
Search for other papers by Colin Farquharson in
Google Scholar
PubMed
Search for other papers by Vicky E MacRae in
Google Scholar
PubMed
Introduction Bone has numerous classical functions including organ protection, calcium and phosphate ion homeostasis, and facilitation of movement. The skeleton is structurally suited to function: strong and flexible enough to bear load
Search for other papers by Kotaro Azuma in
Google Scholar
PubMed
Search for other papers by Stephanie C Casey in
Google Scholar
PubMed
Search for other papers by Masako Ito in
Google Scholar
PubMed
Department of Geriatric Medicine, Department of Developmental and Cell Biology, Division of Radiology, Department of Anti-Aging Medicine, Division of Gene Regulation and Signal Transduction, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
Search for other papers by Tomohiko Urano in
Google Scholar
PubMed
Search for other papers by Kuniko Horie in
Google Scholar
PubMed
Search for other papers by Yasuyoshi Ouchi in
Google Scholar
PubMed
Search for other papers by Séverine Kirchner in
Google Scholar
PubMed
Search for other papers by Bruce Blumberg in
Google Scholar
PubMed
Department of Geriatric Medicine, Department of Developmental and Cell Biology, Division of Radiology, Department of Anti-Aging Medicine, Division of Gene Regulation and Signal Transduction, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
Department of Geriatric Medicine, Department of Developmental and Cell Biology, Division of Radiology, Department of Anti-Aging Medicine, Division of Gene Regulation and Signal Transduction, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
Search for other papers by Satoshi Inoue in
Google Scholar
PubMed
. 1998 , Synold et al . 2001 ). The expression of SXR/PXR was also detected at lower levels in the kidney, lung ( Miki et al . 2005 ), bone (especially in osteoblasts; Tabb et al . 2003 ), and peripheral mononuclear cells ( Albermann et al . 2005
Bone and Endocrine Research Group, Royal Hospital for Sick Children, Glasgow G3 8SJ, UK
Search for other papers by V E MacRae in
Google Scholar
PubMed
Bone and Endocrine Research Group, Royal Hospital for Sick Children, Glasgow G3 8SJ, UK
Search for other papers by C Farquharson in
Google Scholar
PubMed
Bone and Endocrine Research Group, Royal Hospital for Sick Children, Glasgow G3 8SJ, UK
Search for other papers by S F Ahmed in
Google Scholar
PubMed
growth plate chondrocytes and were, therefore, unable to examine the effect of cytokines on the different stages of the chondrocyte life cycle ( Robson et al. 1998 , Koedam et al. 2000 ). The rate of longitudinal bone growth is determined by a
Search for other papers by Dimitrios Agas in
Google Scholar
PubMed
Search for other papers by Guilherme Gusmão Silva in
Google Scholar
PubMed
Search for other papers by Fulvio Laus in
Google Scholar
PubMed
Search for other papers by Andrea Marchegiani in
Google Scholar
PubMed
Search for other papers by Melania Capitani in
Google Scholar
PubMed
Search for other papers by Cecilia Vullo in
Google Scholar
PubMed
Search for other papers by Giuseppe Catone in
Google Scholar
PubMed
Search for other papers by Giovanna Lacava in
Google Scholar
PubMed
Search for other papers by Antonio Concetti in
Google Scholar
PubMed
Search for other papers by Luigi Marchetti in
Google Scholar
PubMed
Search for other papers by Maria Giovanna Sabbieti in
Google Scholar
PubMed
its dual effect depends on experimental and clinical conditions. It was demonstrated that IFN-γ decreases osteoclast differentiation by directly targeting osteoclast precursors, but indirectly stimulates osteoclast formation and bone resorption
Search for other papers by Rhonda D Prisby in
Google Scholar
PubMed
( Burkhardt et al. 1987 ). For years, bone biologists have focused their attention on the cellular and molecular functions of the skeleton in health and disease while often underappreciating the bone vascular network (i.e., the organ system that enables the
Search for other papers by Ghania Ramdani in
Google Scholar
PubMed
The Institute for Pharmacology and Toxicology, University of Bonn, Bonn, Germany
Search for other papers by Nadine Schall in
Google Scholar
PubMed
Search for other papers by Hema Kalyanaraman in
Google Scholar
PubMed
Search for other papers by Nisreen Wahwah in
Google Scholar
PubMed
Search for other papers by Sahar Moheize in
Google Scholar
PubMed
Search for other papers by Jenna J Lee in
Google Scholar
PubMed
Search for other papers by Robert L Sah in
Google Scholar
PubMed
Search for other papers by Alexander Pfeifer in
Google Scholar
PubMed
Search for other papers by Darren E Casteel in
Google Scholar
PubMed
Search for other papers by Renate B Pilz in
Google Scholar
PubMed
levels found in the vasculature, whereas PKG2 expression is limited to specific cell types in bone, intestine, brain and kidney ( Vaandrager et al. 2005 ). PKG1 and 2 are both found in osteoblasts and chondroblasts ( Pfeifer et al. 1996 , Rangaswami
Search for other papers by Gerard Karsenty in
Google Scholar
PubMed
in regulation of whole organism physiology. The organs need to communicate with each other to keep our body functional. Based on this view of physiology, it was recently demonstrated that bone is not only a recipient of hormonal inputs but also an